{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T11:11:09Z","timestamp":1784373069311,"version":"3.55.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.radonc.2023.109937","type":"journal-article","created":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T03:33:36Z","timestamp":1696390416000},"page":"109937","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Treatment options for stage III-N2 pulmonary lymphoepithelioma-like carcinoma: A retrospective cohort study"],"prefix":"10.1016","volume":"189","author":[{"given":"Zan","family":"Hou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiujiao","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baiqiang","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9575-4400","authenticated-orcid":false,"given":"Mingchun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingdian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shining","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runzhe","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2023.109937_b0005","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.5858\/arpa.2018-0149-RS","article-title":"Pulmonary lymphoepithelioma-like carcinoma","volume":"143","author":"Sathirareuangchai","year":"2019","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.radonc.2023.109937_b0010","doi-asserted-by":"crossref","first-page":"e329","DOI":"10.1016\/j.cllc.2018.12.014","article-title":"Clinical features and prognosis of pulmonary lymphoepithelioma-like carcinoma: summary of eighty-five cases","volume":"20","author":"Qin","year":"2019","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.radonc.2023.109937_b0015","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jtho.2021.11.003","article-title":"The 2021 who classification of lung tumors: impact of advances since 2015","volume":"17","author":"Nicholson","year":"2022","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.radonc.2023.109937_b0020","doi-asserted-by":"crossref","first-page":"757085","DOI":"10.3389\/fsurg.2021.757085","article-title":"A rare subtype of non-small cell lung cancer: report of 159 resected stage I-IIIA pulmonary lymphoepithelioma-like carcinoma cases","volume":"8","author":"Jiang","year":"2021","journal-title":"Front Surg"},{"key":"10.1016\/j.radonc.2023.109937_b0025","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1038\/s41467-019-10902-w","article-title":"The genomic landscape of Epstein-Barr virus-associated pulmonary lymphoepithelioma-like carcinoma","volume":"10","author":"Hong","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.radonc.2023.109937_b0030","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jtho.2017.10.031","article-title":"Clinical significance of plasma Epstein-Barr virus DNA in pulmonary lymphoepithelioma-like carcinoma (lelc) patients","volume":"13","author":"Xie","year":"2018","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.radonc.2023.109937_b0035","doi-asserted-by":"crossref","first-page":"e28349","DOI":"10.1002\/jmv.28349","article-title":"Prognostic significance of circulating Epstein-Barr virus DNA in pulmonary lymphoepithelioma-like carcinoma: a meta-analysis and validation study","volume":"95","author":"Wei","year":"2023","journal-title":"J Med Virol"},{"key":"10.1016\/j.radonc.2023.109937_b0040","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.3390\/cancers12082050","article-title":"Resectable IIIA-N2 non-small-cell lung cancer (NSCLC): in search for the proper treatment","volume":"12","author":"Brascia","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.radonc.2023.109937_b0045","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jtho.2021.08.006","article-title":"Postoperative radiation therapy should be used for completely resected stage III-N2 NSCLC in select patients","volume":"17","author":"Liu","year":"2022","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.radonc.2023.109937_b0050","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jtho.2021.09.005","article-title":"Postoperative Radiation therapy should not be used for the therapy of stage III-N2 NSCLC","volume":"17","author":"Faivre-Finn","year":"2022","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.radonc.2023.109937_b0055","doi-asserted-by":"crossref","first-page":"4748","DOI":"10.1002\/cncr.27452","article-title":"Primary pulmonary lymphoepithelioma-like carcinoma: fifty-two patients with long-term follow-up","volume":"118","author":"Liang","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2023.109937_b0060","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jtho.2015.09.009","article-title":"The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer","volume":"11","author":"Goldstraw","year":"2016","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.radonc.2023.109937_b0065","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/j.jtho.2020.09.006","article-title":"Complete resection in lung cancer surgery: from definition to validation and beyond","volume":"15","author":"Rami-Porta","year":"2020","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.radonc.2023.109937_b0070","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1056\/NEJMoa1709937","article-title":"Durvalumab after chemoradiotherapy in stage III non-small-cell lung cancer","volume":"377","author":"Antonia","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2023.109937_b0075","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0140-6736(09)60737-6","article-title":"Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small cell lung cancer","volume":"374","author":"Albain","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.radonc.2023.109937_b0080","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1093\/jnci\/djk093","article-title":"Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non\u2013small-cell lung cancer","volume":"99","author":"van Meerbeeck","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.radonc.2023.109937_b0085","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/s41379-019-0391-9","article-title":"A multicenter analysis of genomic profiles and pd-l1 expression of primary lymphoepithelioma-like carcinoma of the lung","volume":"33","author":"Xie","year":"2020","journal-title":"Modern Pathol"},{"key":"10.1016\/j.radonc.2023.109937_b0090","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.lungcan.2015.03.017","article-title":"PD-L1 is highly expressed in lung lymphoepithelioma-like carcinoma: a potential rationale for immunotherapy","volume":"88","author":"Chang","year":"2015","journal-title":"Lung Cancer"},{"key":"10.1016\/j.radonc.2023.109937_b0095","doi-asserted-by":"crossref","first-page":"33019","DOI":"10.18632\/oncotarget.5028","article-title":"PD-L1 is remarkably over-expressed in EBV-associated pulmonary lymphoepithelioma-like carcinoma and related to poor disease-free survival","volume":"6","author":"Fang","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.radonc.2023.109937_b0100","first-page":"1451","article-title":"Positive expression of programmed death ligand-1 correlates with superior outcomes and might be a therapeutic target in primary pulmonary lymphoepithelioma-like carcinoma","volume":"8","author":"Jiang","year":"2015","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.radonc.2023.109937_b0105","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1002\/ijc.34426","article-title":"Exploration of immunotherapy in advanced pulmonary lymphoepithelioma like carcinoma","volume":"152","author":"Pang","year":"2023","journal-title":"Int J Cancer"},{"key":"10.1016\/j.radonc.2023.109937_b0110","doi-asserted-by":"crossref","first-page":"1015444","DOI":"10.3389\/fimmu.2022.1015444","article-title":"PD-1 inhibition plus platinum-based chemotherapy (PBC) or PBC alone in the first-line treatment of locally advanced or metastatic pulmonary lymphoepithelioma like carcinoma","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.radonc.2023.109937_b0115","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1200\/JCO.21.01308","article-title":"Five-year survival outcomes from the PACIFIC trial: Durvalumab after chemoradiotherapy in stage III non-small-cell lung cancer","volume":"40","author":"Spigel","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2023.109937_b0120","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S1470-2045(21)00606-9","article-title":"Postoperative radiotherapy versus no postoperative radiotherapy in patients with completely resected non-small-cell lung cancer and proven mediastinal N2 involvement (lung ART): an open-label, randomised, phase 3 trial","volume":"23","author":"Pechoux","year":"2022","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2023.109937_b0125","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1001\/jamaoncol.2021.1910","article-title":"Effect of postoperative radiotherapy for patients with pIIIA-N2 non-small cell lung cancer after complete resection and adjuvant chemotherapy: the phase 3 PORT-C randomized clinical trial","volume":"7","author":"Hui","year":"2021","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.radonc.2023.109937_b0130","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.lungcan.2019.09.007","article-title":"First-line platinum-based chemotherapy and survival outcomes in locally advanced or metastatic pulmonary lymphoepithelioma-like carcinoma","volume":"137","author":"Lin","year":"2019","journal-title":"Lung Cancer"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814023898310?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814023898310?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T05:27:06Z","timestamp":1759123626000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814023898310"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":26,"alternative-id":["S0167814023898310"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2023.109937","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment options for stage III-N2 pulmonary lymphoepithelioma-like carcinoma: A retrospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2023.109937","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109937"}}